Clinical and member reports include: Studies outside Noom, including a 2,700-person Denmark trial, suggest users who stayed at microdose levels saw 16% body weight loss over 64 weeks, with minimized side effects (fatigue, GI upset) and improved cholesterol, markers of inflammation, and overall health. One user lost 25 pounds through Noom GLP 1 Cost support, reporting, Taking a GLP-1 significantly reduced my appetite, which meant I had to be intentional about getting enough nutrients
They're putting effort into their health, their metabolism, their weight, and now it's paying off
Most weight loss begins after reaching higher doses, which takes about 16 weeks, as semaglutide is gradually increased to reduce side effects
Tirzepatides long-term data is accumulating but looks similarly favorable